Schedule 13D ownership disclosure

Candel Therapeutics Inc

Security class unavailable · CUSIP: 137404109

Event date: 2021-07-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
40,733,163
Percent of class
13.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-22-001918
Form type
SC 13D
Filer
Candel Therapeutics, Inc.
CIK
CIK 1841387
Filed
Feb 14, 2022
Reporting period
Jul 29, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub